AdComconf 0.98

imetelstat — AdCom

$GERN · GERON CORP · transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes who have failed to respond, or have lost response to, or are ineligible for erythropoiesis-stimulating agents

Event date

March 14, 2024

814 days ago

Sponsor runway

3 mo

$68.9M liquid

Evidence

“announcing the results of the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee, virtually held on March 14, 2024, in connection with the Company's New Drug Application for imetelstat for the treatment of transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes who have failed to respond, or have lost response to, or are ineligible for erythropoiesis-stimulating agents”

Source: 8-K filed 2024-03-14View on EDGAR ↗0000950170-24-031475

Comparable historical adcoms· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

13 insiders · 0 buys · 4 sells

Sell

2024-06-10

Feller Faye

EVP, Chief Medical Officer

287,900 @ $4.63$1.33M

Exercise

2024-06-10

Feller Faye

EVP, Chief Medical Officer

155,400 @ $1.29$201K

Exercise

2024-06-10

Feller Faye

EVP, Chief Medical Officer

112,500 @ $1.06$119K

Sell

2024-06-10

Kapur Anil

EVP, Corp Strategy & CCO

421,875 @ $4.64$1.96M

Exercise

2024-06-10

Feller Faye

EVP, Chief Medical Officer

20,000 @ $1.06$21K

Exercise

2024-06-10

Kapur Anil

EVP, Corp Strategy & CCO

421,875 @ $1.06$447K

Grant

2024-06-06

Feller Faye

EVP, Chief Medical Officer

200,000 @ ——

Grant

2024-06-06

SCARLETT JOHN A

Chairman, President and CEO

1,000,000 @ ——

Grant

2024-06-06

Samuels Scott Alan

EVP, Chief Legal Officer

250,000 @ ——

Grant

2024-06-06

Kapur Anil

EVP, Corp Strategy & CCO

250,000 @ ——

Grant

2024-06-06

ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER

250,000 @ ——

Grant

2024-06-06

GRETHLEIN ANDREW J

EVP, Chief Operating Officer

452,804 @ ——

Grant

2024-06-06

Feller Faye

EVP, Chief Medical Officer

50,000 @ ——

Sell

2024-06-04

SCARLETT JOHN A

Chairman, President and CEO

600,000 @ $4.00$2.40M

Exercise

2024-06-04

SCARLETT JOHN A

Chairman, President and CEO

600,000 @ $2.54$1.52M

Exercise10b5-1

2024-05-15

LAWLIS V BRYAN

Director

35,000 @ $1.94$68K

Sell10b5-1

2024-05-15

LAWLIS V BRYAN

Director

35,000 @ $3.75$131K

Grant

2024-05-09

O'Farrell Elizabeth G.

Director

180,000 @ ——

Grant

2024-05-09

McDonald John F

Director

180,000 @ ——

Grant

2024-05-09

Aggarwal Gaurav

Director

180,000 @ ——

Grant

2024-05-09

Bir Dawn Carter

Interim President and CEO

180,000 @ ——

Grant

2024-05-09

Spiegel Robert J.

Director

180,000 @ ——

Grant

2024-05-09

LAWLIS V BRYAN

Director

180,000 @ ——

Grant

2024-05-09

Molineaux Susan

Director

180,000 @ ——

Grant

2024-03-29

Spiegel Robert J.

Director

2,462 @ ——

Grant

2024-02-14

SCARLETT JOHN A

Chairman, President and CEO

3,000,000 @ ——

Grant

2024-02-14

Kapur Anil

EVP, Corp Strategy & CCO

750,000 @ ——

Grant

2024-02-14

Samuels Scott Alan

EVP, Chief Legal Officer

850,000 @ ——

Grant

2024-02-14

ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER

850,000 @ ——

Grant

2024-02-14

GRETHLEIN ANDREW J

EVP, Chief Operating Officer

1,200,000 @ ——

Grant

2024-02-14

Feller Faye

EVP, Chief Medical Officer

750,000 @ ——

Grant

2023-12-29

Spiegel Robert J.

Director

3,406 @ ——

Grant

2023-12-29

Molineaux Susan

Director

6,220 @ ——

Grant

2023-12-29

Aggarwal Gaurav

Director

1,970 @ ——

Date	Insider	Action	Shares	Price	Value
2024-06-10	Feller FayeEVP, Chief Medical Officer	Sell	287,900	$4.63	$1.33M
2024-06-10	Feller FayeEVP, Chief Medical Officer	Exercise	155,400	$1.29	$201K
2024-06-10	Feller FayeEVP, Chief Medical Officer	Exercise	112,500	$1.06	$119K
2024-06-10	Kapur AnilEVP, Corp Strategy & CCO	Sell	421,875	$4.64	$1.96M
2024-06-10	Feller FayeEVP, Chief Medical Officer	Exercise	20,000	$1.06	$21K
2024-06-10	Kapur AnilEVP, Corp Strategy & CCO	Exercise	421,875	$1.06	$447K
2024-06-06	Feller FayeEVP, Chief Medical Officer	Grant	200,000	—	—
2024-06-06	SCARLETT JOHN AChairman, President and CEO	Grant	1,000,000	—	—
2024-06-06	Samuels Scott AlanEVP, Chief Legal Officer	Grant	250,000	—	—
2024-06-06	Kapur AnilEVP, Corp Strategy & CCO	Grant	250,000	—	—
2024-06-06	ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER	Grant	250,000	—	—
2024-06-06	GRETHLEIN ANDREW JEVP, Chief Operating Officer	Grant	452,804	—	—
2024-06-06	Feller FayeEVP, Chief Medical Officer	Grant	50,000	—	—
2024-06-04	SCARLETT JOHN AChairman, President and CEO	Sell	600,000	$4.00	$2.40M
2024-06-04	SCARLETT JOHN AChairman, President and CEO	Exercise	600,000	$2.54	$1.52M
2024-05-15	LAWLIS V BRYANDirector	Exercise10b5-1	35,000	$1.94	$68K
2024-05-15	LAWLIS V BRYANDirector	Sell10b5-1	35,000	$3.75	$131K
2024-05-09	O'Farrell Elizabeth G.Director	Grant	180,000	—	—
2024-05-09	McDonald John FDirector	Grant	180,000	—	—
2024-05-09	Aggarwal GauravDirector	Grant	180,000	—	—
2024-05-09	Bir Dawn CarterInterim President and CEO	Grant	180,000	—	—
2024-05-09	Spiegel Robert J.Director	Grant	180,000	—	—
2024-05-09	LAWLIS V BRYANDirector	Grant	180,000	—	—
2024-05-09	Molineaux SusanDirector	Grant	180,000	—	—
2024-03-29	Spiegel Robert J.Director	Grant	2,462	—	—
2024-02-14	SCARLETT JOHN AChairman, President and CEO	Grant	3,000,000	—	—
2024-02-14	Kapur AnilEVP, Corp Strategy & CCO	Grant	750,000	—	—
2024-02-14	Samuels Scott AlanEVP, Chief Legal Officer	Grant	850,000	—	—
2024-02-14	ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER	Grant	850,000	—	—
2024-02-14	GRETHLEIN ANDREW JEVP, Chief Operating Officer	Grant	1,200,000	—	—
2024-02-14	Feller FayeEVP, Chief Medical Officer	Grant	750,000	—	—
2023-12-29	Spiegel Robert J.Director	Grant	3,406	—	—
2023-12-29	Molineaux SusanDirector	Grant	6,220	—	—
2023-12-29	Aggarwal GauravDirector	Grant	1,970	—	—

← All catalysts for $GERN